Pharma gets exemption in Trump’s new tariff policy
Pharma Stocks: US President Donald Trump’s new tariff policy has come into force. Since the implementation of the new tariff policy, there is a major decline in stock markets around the world. The Indian stock markets were also open today with a steep decline. However, in this heavy decline, the country’s pharma was seen climbing like a sector rocket. On Thursday, in early trade, pharma stocks saw an increase of up to 10 percent. The Nifty Pharma Index was trading with a gain of 4.5 percent. However, they have recorded a slight decline over time.
Gland Pharma’s biggest lead in shares
In early trade on Thursday, Gland Pharma shares were trading with a gain of about 10 percent. After this, Aurobindo Pharma was trading up 7.22 percent, Dr. Reddy 5.83 percent and Zidas Life’s shares were trading up by 5.33 percent. Apart from these, shares of Sunpharma, Mankind and Cipla were also trading rapidly.
At what price is pharma share trading right now
However, Gland Pharma shares gained 3.97% (Rs 60.90) at Rs 1596.00 at 10.55 am, Aurobindo Pharma rose by Rs 3.24% (Rs 47) to Rs 1499.70, Dr. Reddy’s shares rose by Rs 1.98% (Rs 22.75) with Rs 1172.50, Gidas Life 2.55 percent (Rs 22.75) gained Rs 2.55 per cent (Rs 22.75). 914.00 was trading at a price of Rs 914.00, Sun arferma up to Rs 1779.50, Rs.136% (Rs 8.75) with a gain of Rs. 2429.90 and Cipla’s shares at a price of Rs 1499.70, with a gain of Rs.
Pharma gets exemption in Trump’s new tariff policy
Let us tell you that Donald Trump’s new tariff policy is the biggest and important reason behind this boom in pharma stocks. In fact, the goods that Trump has exempted from the tariff from the tariff also includes the name of Pharma. That is, the tariff will not be imposed on the export of medicines as per Trump’s new tariff policy. Let us tell you that Indian pharma companies export medicines to the US at large levels. Not only this, India is one of the largest exporters in America in terms of certain medicines.
Latest business news